Related Experiment Video
Updated: May 14, 2026

Demystifying In Vivo Bioluminescence Imaging of a Chagas Disease Mouse Model for Drug Efficacy Studies
Published on: May 31, 2024
Immunosuppression and Chagas disease: a management challenge
María-Jesús Pinazo1, Gerard Espinosa, Cristina Cortes-Lletget
1Barcelona Centre for International Health Research (CRESIB), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain. MPINAZO@clinic.ub.es
Immunosuppression can reactivate Trypanosoma cruzi (Chagas disease) infection. Early antiparasitic treatment, like benznidazole, is crucial for preventing severe reactivation in at-risk patients.
Area of Science:
- Infectious Diseases
- Immunology
- Parasitology
Background:
- Immunosuppression significantly alters the course of Trypanosoma cruzi infection.
- Chagas disease reactivation is a serious concern in immunocompromised individuals.
- Trypanosoma cruzi infection is an opportunistic infection, particularly in AIDS patients.
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Myocarditis III: Medical Management
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pericarditis III: Medical Management
Endocarditis III: Medical Management
Myocarditis IV: Nursing Management

